Skip to main content

Silo Pharma, Inc.

SILO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001514183

No open-market purchases or sales by Silo Pharma, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q3 2026, worth $451.7K in total; no superinvestor holds it.

Key figures

Market capClose on Nov 19, 2026
$4.05M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +4 vs. previous quarter
13
13F valueReported value at the end of Q3 2026
$451.7K
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$72.1K
0.0% year over year
Net income, FY2025
-$4.23M
No comparable prior period
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q3 FY2026
$0
−100.0% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $4.23M (5863.5% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
13.8K
Shares sold short
Change
−8.29K
−37.6% vs. previous
Days to cover
1.07
At average daily volume

Superinvestors holding SILO, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding SILO at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Silo Pharma, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 16, 2025 (view filing)6:34 PM ETDec 151 dayWeisblum EricChief Executive OfficerPPurchase+5.00K$0.415+$2.08K+2.4%216.9K after2 lots
Nov 21, 2025 (view filing)6:35 PM ETNov 20-211 dayWeisblum EricChief Executive OfficerPPurchase+2.00K$0.3675+$735+1.0%211.9K after2 lots
Nov 20, 2025 (view filing)4:00 PM ETNov 18-192 daysWeisblum EricChief Executive OfficerPPurchase+12.0K$0.4039+$4.85K+6.1%209.9K after2 lots
May 28, 2025 (view filing)4:30 PM ETMay 271 dayWeisblum EricChief Executive OfficerPPurchase+10.0K$0.4329+$4.33K+5.3%197.9K after
Dec 16, 2024 (view filing)Dec 133 daysWeisblum EricCEO and PresidentPPurchase+2.50K$0.84+$2.10K+1.3%187.9K after
Nov 22, 2024 (view filing)Nov 20-222 daysWeisblum EricCEO and PresidentPPurchase+5.00K$0.925+$4.63K+2.8%185.4K after2 lots
Jun 13, 2024 (view filing)Jun 11-122 daysWeisblum EricCEO and PresidentPPurchase+5.00K$1.11+$5.53K+2.9%180.4K after2 lots
Apr 8, 2024 (view filing)Apr 4-54 daysWeisblum EricCEO and PresidentPPurchase+1.00K$1.99+$1.99K+0.6%175.4K after2 lots
Apr 1, 2024 (view filing)Mar 28-Apr 14 daysWeisblum EricCEO and PresidentPPurchase+4.51K$1.93+$8.71K+2.7%174.4K after2 lots
Dec 21, 2023 (view filing)Dec 19-202 daysWeisblum EricCEO and PresidentPPurchase+700$1.62+$1.14K+0.4%169.9K after2 lots

Top 10 13F holders, Q3 2026

See all 13 holders

The largest institutional positions in Silo Pharma, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding SILO in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Anson Funds Management LP103,983$157.0K0.02%+103,983New
AdvisorShares Investments LLC103,472$156.2K0.02%+27,890+36.9%Added
Renaissance Technologies LLC23,500$35.5K0.00%+23,500New
Citadel Advisors LLC16,441$24.8K0.00%−359−2.1%Reduced
Vanguard Capital Management LLC11,956$18.1K0.00%00.0%Unchanged
Two Sigma Investments, LP11,515$17.4K0.00%+11,515New
Geode Capital Management, LLC11,283$17.0K0.00%+11,283New
Virtu Financial LLC10,459$16.0K0.00%+10,459New
FNY Investment Advisers, LLC5,000$7.00K0.00%−32,507−86.7%Reduced
Vanguard Fiduciary Trust Co874$1.32K0.00%00.0%Unchanged

Holders of 5% or more of SILO

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Silo Pharma, Inc..

Largest holders of SILO from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Intracoastal Capital, LLC13G/A9.99%1.48M shares0.00 ppfrom 9.99%Jun 13, 20246 filingsFeb 13, 2026SEC
Intracoastal Capital, LLC13G/A9.99%176.2K shares0.00 ppfrom 9.99%Aug 13, 20262 filingsNov 10, 2026SEC
AdvisorShares Trust13G6.69%75.6K sharesNewJul 8, 20261 filingJul 8, 2026SEC
Anson Funds Management LP13G6.60%104.0K sharesNewNov 16, 20261 filingNov 16, 2026SEC